| The Hydration Pharmaceuticals Company Limited (HPC) ORDINARY FULLY PAID |
Consumer Staple |
$1 |
Appendix 4E and Annual Report
|
27 Feb 2026 3:27PM |
$0.005 |
$0.003 |
fallen by
40%
|
|
HPC - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from continuing operations was $2.47 million.
- Loss after tax for the year was $2.86 million.
- Divestiture of non-US assets was completed.
- Focus was on US market operations.
- Total equity decreased to $1.42 million.
- No dividends were paid during the year.
- Detailed financial statements and notes are included.
- Remuneration policies and strategic focus discussed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amplitude Energy Limited (AEL) ORDINARY FULLY PAID |
Energy |
$504 |
Change in substantial holding
|
27 Feb 2026 3:27PM |
$2.590 |
$1.680 |
fallen by
35.14%
|
|
| Brisbane Broncos Limited (BBL) ORDINARY FULLY PAID |
Communication Services |
$136 |
Full Year Statutory Accounts
|
27 Feb 2026 3:25PM |
$1.620 |
$1.385 |
fallen by
14.51%
|
|
BBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 20.5% to $98.31 million.
- Net profit rose by 35.9% to $7.77 million.
- A total dividend of 3.0 cents per share was declared.
- Increased expenditure on player costs and community programs.
- Strong financial position with significant cash assets.
- Audit confirmed no contraventions of professional conduct.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SiteMinder Limited (SDR) ORDINARY FULLY PAID |
Information Technology |
$818 |
Ceasing to be a substantial holder
|
27 Feb 2026 3:23PM |
$3.605 |
$2.890 |
fallen by
19.83%
|
|
| Sunstone Metals Ltd (STM) ORDINARY FULLY PAID |
Materials |
$78 |
Porotillo high grade surface mineralisation - amendment
|
27 Feb 2026 3:23PM |
$0.450 |
$0.345 |
fallen by
23.33%
|
|
| Centuria Industrial REIT (CIP) ORDINARY UNITS FULLY PAID |
Real Estate |
$1,854 |
Appendix 3Y - Roger Dobson
|
27 Feb 2026 3:21PM |
$3.210 |
$2.970 |
fallen by
7.48%
|
|
| WhiteHawk Limited (WHK) ORDINARY FULLY PAID |
Information Technology |
$7 |
Preliminary Final Report
|
27 Feb 2026 3:21PM |
$0.006 |
$0.006 |
fallen by
0%
|
|
WHK - Price-sensitive ASX Announcement
Full Release
Key Points
- Recognized US$2.1M revenue in 2025.
- Net loss after tax of US$1.2M.
- Signed a Teaming Agreement with LEIDOS for the APOLLO contract.
- Launched RiskWise joint solution with Novera.
- Achieved key contracts in cybersecurity and defense sectors.
- Expanded client base focusing on AUKUS, CMMC, and AU Essential 8 Compliance.
- Revenue included US$801K unearned revenue from 2024.
- Net asset position improved to US$450K.
- Cash flow challenges with a US$1.57M net operating cash outflow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Botanix Pharmaceuticals Ltd (BOT) ORDINARY FULLY PAID |
Health Care |
$76 |
Appendix 4D and Half Year Report
|
27 Feb 2026 3:20PM |
$0.059 |
$0.028 |
fallen by
52.54%
|
|
BOT - Price-sensitive ASX Announcement
Full Release
Key Points
- Botanix Pharmaceuticals Ltd increased sales revenue to $16.5 million in H1 FY26.
- Net loss after tax for the period was $33.2 million.
- Sofdra prescriptions grew by 171% due to expanded sales efforts.
- The company aims to reduce its cost of goods sold by securing alternative API suppliers.
- Botanix plans to expand Sofdra licensing to other regions to increase revenue.
- A capital raising of approximately $45 million was announced.
- The financial position as of 31 December 2025 showed net assets of $54 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alternative Investment Trust (AIQ) ORDINARY UNITS FULLY PAID |
Financials |
$75 |
Appendix 4G Corporate Governance Statement
|
27 Feb 2026 3:18PM |
$1.490 |
$1.400 |
fallen by
6.04%
|
|
| 4DMedical Limited (4DX) ORDINARY FULLY PAID |
Health Care |
$2,472 |
Application for quotation of securities - 4DX
|
27 Feb 2026 3:18PM |
$3.790 |
$4.170 |
risen by
10.03%
|
|
| Alternative Investment Trust (AIQ) ORDINARY UNITS FULLY PAID |
Financials |
$75 |
Full Year Statutory Accounts
|
27 Feb 2026 3:17PM |
$1.490 |
$1.400 |
fallen by
6.04%
|
|
| Thorney Technologies Ltd (TEK) ORDINARY FULLY PAID |
Financials |
$35 |
Notification of cessation of securities - TEK
|
27 Feb 2026 3:13PM |
$0.125 |
$0.095 |
fallen by
24%
|
|
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$93 |
Notification of cessation of securities - TOP
|
27 Feb 2026 3:10PM |
$0.640 |
$0.550 |
fallen by
14.06%
|
|
| Westpac Banking Corporation (WBC) ORDINARY FULLY PAID |
Financials |
$122,584 |
Notification regarding unquoted securities - WBC
|
27 Feb 2026 3:07PM |
$42.610 |
$35.840 |
fallen by
15.89%
|
|
| Peoplein Limited (PPE) ORDINARY FULLY PAID |
Industrials |
$61 |
Completion of Acquisition of Infrawork Holdings
|
27 Feb 2026 3:04PM |
$0.665 |
$0.555 |
fallen by
16.54%
|
|
| Variscan Mines Limited (VAR) ORDINARY FULLY PAID |
Materials |
$7 |
Proposed Application for Quotation of Unlisted Options
|
27 Feb 2026 3:01PM |
$0.009 |
$0.006 |
fallen by
33.33%
|
|
| Synertec Corporation Limited (SOP) ORDINARY FULLY PAID |
Industrials |
$13 |
FY26 H1 Financial Results and Operational Highlights
|
27 Feb 2026 2:58PM |
$0.024 |
$0.025 |
risen by
4.17%
|
|
SOP - Price-sensitive ASX Announcement
Full Release
Key Points
- 20% increase in group revenue to $10.2 million.
- Net operating cash inflow of $0.5 million, first since FY19.
- Cost savings of $1.3 million achieved.
- Powerhouse revenue increased 22% to $1.2 million.
- Engineering revenue rose 20%, with 144% increase in EBITDA.
- 100% compliance with financial covenants maintained.
- Powerhouse operational reliability over 99.9%.
- Strong tender pipeline in Powerhouse and Engineering sectors.
- Strategic geographic expansion in Australia.
- Focus on scalable deployment and long-term partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$7 |
Appendix 4G and Corporate Governance Statement
|
27 Feb 2026 2:57PM |
$0.028 |
$0.014 |
fallen by
49.09%
|
|
| I Synergy Group Limited (IS3) ORDINARY FULLY PAID |
Information Technology |
$17 |
Appendix 4E and Preliminary Final Report
|
27 Feb 2026 2:57PM |
$0.008 |
$0.010 |
risen by
25%
|
|
IS3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Decrease in revenue by 15.63% to AUD 810,000.
- Net loss increased by 21.51% to AUD 339,000.
- No dividend declared for the financial year.
- Compliance with Australian Accounting Standards.
- Emphasis of Matter related to going concern in audit.
- Net liabilities of AUD 1,001,000 as of year-end.
- Cash and cash equivalents at AUD 546,000 at year-end.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OpenLearning Limited (OLL) ORDINARY FULLY PAID |
Information Technology |
$16 |
Preliminary Final Report
|
27 Feb 2026 2:56PM |
$0.027 |
$0.021 |
fallen by
22.22%
|
|
OLL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 39.4% to $3,182,221.
- Net loss of $4,096,692 for the year 2025.
- Significant SaaS contract growth in Philippines and Malaysia.
- AI tools integrated into the platform, boosting institutional sales.
- Balance sheet strengthened through $2.6 million equity placement.
- Challenges include customer retention and competitive innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Appen Limited (APX) ORDINARY FULLY PAID |
Information Technology |
$328 |
Change of Director's Interest Notice - Mr Ryan Kolln
|
27 Feb 2026 2:55PM |
$1.855 |
$1.225 |
fallen by
33.96%
|
|
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$7 |
FY25 Appendix 4E and Annual Report
|
27 Feb 2026 2:55PM |
$0.028 |
$0.014 |
fallen by
49.09%
|
|
IBX - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported an increase in loss after income tax to AUD 4,309,456.
- Total comprehensive income slightly improved due to currency translation gains.
- Total assets decreased and liabilities increased, leading to higher equity deficiency.
- Engaged in significant financing activities through share and convertible note issuance.
- Detailed changes in equity, cash flows, and financial instruments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASF Group Limited (AFA) ORDINARY FULLY PAID |
Financials |
$49 |
Half Yearly Report and Accounts
|
27 Feb 2026 2:54PM |
$0.060 |
$0.062 |
risen by
3.33%
|
|
AFA - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit after tax for the half-year was $494,166.
- Total comprehensive income was $502,758.
- Net cash used in operating activities was $750,159.
- Equity increased to $2,172,366.
- No dividends were paid, recommended, or declared.
- A material uncertainty exists regarding going concern.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Synertec Corporation Limited (SOP) ORDINARY FULLY PAID |
Industrials |
$13 |
Appendix 4D - Interim Financial Report - FY26 H1
|
27 Feb 2026 2:53PM |
$0.024 |
$0.025 |
risen by
4.17%
|
|
SOP - Price-sensitive ASX Announcement
Full Release
Key Points
- Synertec Corporation Limited reported a total revenue of $10,182,811 for the half-year ended 31 December 2025.
- The company experienced a total comprehensive loss of $2,530,453 during this period.
- The net tangible assets per share decreased from 1.5 cents to 0.5 cents, marking a 68% reduction.
- No dividends were declared or paid during the reporting period.
- The company issued 7.8 million warrants as part of an extension facility, replacing 18.5 million warrants previously issued.
- Revenue from the Engineering segment was $7,651,733, while the Technology segment generated $1,207,875.
- Operating segments are divided into Engineering Solutions and Technology and Future Business.
- The company remained compliant with all financing covenants and continued to operate on a going concern basis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Raptor Metals Ltd (RAP) ORDINARY FULLY PAID |
Materials |
$19 |
Application for quotation of securities - RAP
|
27 Feb 2026 2:53PM |
$0.056 |
$0.049 |
fallen by
12.50%
|
|
Call 1300 880 160
Start a chat
Schedule a call
